| Product Code: ETC6175334 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Bacteriophages Therapy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Australia Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Australia Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Australia Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Australia Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant bacterial infections |
4.2.2 Growing awareness and acceptance of bacteriophage therapy as an alternative treatment |
4.2.3 Government initiatives to promote research and development in phage therapy |
4.3 Market Restraints |
4.3.1 Limited clinical evidence supporting the efficacy and safety of bacteriophage therapy |
4.3.2 Regulatory challenges and approval processes for phage therapy products |
4.3.3 Lack of standardized manufacturing processes for bacteriophages |
5 Australia Bacteriophages Therapy Market Trends |
6 Australia Bacteriophages Therapy Market, By Types |
6.1 Australia Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Australia Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Australia Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Australia Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Australia Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Australia Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Australia Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Australia Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Australia Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Australia Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Australia Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Australia Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Australia Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Australia Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Australia Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Australia Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Australia Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Australia Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Australia Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Australia Bacteriophages Therapy Market Export to Major Countries |
7.2 Australia Bacteriophages Therapy Market Imports from Major Countries |
8 Australia Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted on bacteriophage therapy in Australia |
8.2 Percentage increase in funding for phage therapy research and development |
8.3 Adoption rates of bacteriophage therapy in Australian healthcare facilities |
9 Australia Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Australia Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Australia Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Australia Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Bacteriophages Therapy Market - Competitive Landscape |
10.1 Australia Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Australia Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here